Vycor Medical Inc
VYCO· OTC
Released Nov 12, 2021
10-Q filed Nov 12, 2021, 43 days after period end · 0001493152-21-028118
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Revenue | $332.09K | $275.93K | $322.88K | $456.21K |
| Net Income | $3.69K | -$198.29K | -$209.61K | -$152.18K |
| EPS Diluted | -$0.01 |
Vycor Medical Inc · CIK 1424768 · Engraved from SEC EDGAR
| -$0.01 |
| -$0.02 |
| -$0.01 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.